| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |